To define the change in the prevalence of reported left atrial enlargement (LAE) brought by using volumetric rather than linear measurements and to detect whether individuals with LAE that would have been missed by linear measurements represent a distinct subgroup of patients.
Introduction
The left atrium (LA) fulfils a mechanical role as both a reservoir for continuously incoming pulmonary vein inflow and an active participant to left ventricular (LV) filling. 1 Clinically, LA enlargement (LAE) is associated with mitral valve disease, long-standing atrial fibrillation, increased LV filling pressures, and LV volume overload conditions. A wealth of data suggests that patients with LAE have poorer long-term cardiovascular outcome and that LAE can be used for risk stratification in heart failure, atrial fibrillation, arterial hypertension (AHT), and stroke. 2 -5 Historically, the LA has been measured in its antero-posterior diameter in the parasternal longaxis view using either M-mode or two-dimensional (2D) imaging. 6, 7 The value of these linear measurements is supported by strong clinical correlations reported in the literature. 2, 8 Recent data suggest that LAE defined by LA area or volume rather than by the antero-posterior diameter has an even stronger association with the outcome of cardiac patients 9, 10 and that 2D volume measurements have a better correlation with 3D volumes than other techniques. 10 -13 Updated echocardiographic guidelines refer to both linear and volume measurements but stop short of endorsing volume measurements as the preferred method to assess LAE. 7 Most echocardiographic services still rely on diameter measurements, and volume calculations are used mainly for research purposes. Both long-established practice and uncertainties about the potential alterations on echocardiographic reporting brought by a change in routine measurements may explain the lack of wide-scale espousal of this new approach. This is a prospective study, designed to assess the potential impact of switching to routine volumetric LA assessment on the reported prevalence of LAE and whether individuals with LAE that would have been missed by linear measurements represent a distinct subgroup of patients.
Methods

Study population
We enrolled 200 consecutive patients aged 50 years or more, referred for echocardiographic scans at the Department of Cardiology, Royal Liverpool University Hospital. The presence of AHT, diabetes, and coronary disease was documented by specifically questioning the patient and from the patient's case file. Arterial hypertension was defined as the systolic or diastolic blood pressure of .140 or .90 mmHg, respectively, or the current use of antihypertensive drugs. Diabetes mellitus (DM) was defined as two documented blood glucose levels .7 mmol/L or post-prandial serum glucose of .11 mmol/L or known diabetes controlled either with diet or antiglycaemic medications. Age above 50 years was the only inclusion criterion due to the expected increased prevalence of LAE in these patients 14 and paced rhythm and poor-quality images were the only exclusion criteria. LA volume measurements were not obtainable in only 12 cases but overall 32 patients had to be excluded due to either paced rhythm, poor-quality studies precluding LA measurements by both longitudinal diameter and volumes, or refuse to participate in the study. The remaining 168 patients (age: 69 + 10 years, 75 males and 93 females) are the object of this report. The protocol was approved by the hospital Ethics Committee and written informed consent was obtained in each subject.
Echocardiography
Echocardiography was performed using a commercially available Philips IE 33 ultrasound system. All studies were performed by the same experienced sonographer and included a full 2D and Doppler examination following accepted guidelines. 7, 15 As a rule, measurements were performed with the patient in left lateral decubitus, withheld respiration at the time allowing optimal visualization. End-diastole was defined as the onset of QRS and end-systole as the last frame preceding mitral valve opening. One to three measurements were performed for patients in sinus rhythm and three to five measurements were used for patients in atrial fibrillation. 7 The LA antero-posterior diameter was measured at end-systole in the parasternal long-axis view using either 2D or 2D-guided M-mode measurements. 7 The LA volume was obtained by Simpson's rule using the built-in software of the machine. For this purpose, LA areas were manually traced at endsystole in apical four-and two-chamber views. 7 No more than 20% atrial wall drop was considered acceptable for tracing. Diastolic function was assessed using both mitral valve inflow pulsed-wave (PW) Doppler and mitral annulus PW tissue Doppler, 16 and LV mass was calculated using M-mode measurements and the Devereux 17 formula. LV systolic function was visually assessed in all patients and the ejection fraction was calculated using the Simpson's method whenever possible. 
Frequency of left atrial enlargement by different methods
The prevalence of LAE in the study population rose from 68 (40%) when diagnosed by the antero-posterior diameter, to 85 (50%) by LA area, 109 (65%) by LA volume, and 126 (75%) by LA volume indexed for BSA, P , 0.001. Indexing the diameter measurement for BSA did not improve the detection rate ( Figure 1) . The use of volume calculation resulted in a 60% increase in the number of patients diagnosed with LAE when compared with the use of diameter measurement. The proportion of patients with LAE by volume but missed by diameter was higher in patients with normal LV contractility, sinus rhythm, and no mitral valve disease ( Table 2 ). The concordance for the presence of LAE by the diameter and volume was 111 of 168 (66%). Out of the 57 patients in whom the methods were in disagreement, 49 had LAE by volume but not by diameter (Figure 2) , whereas 8 had LAE by diameter but not by volume.
Comparison of patients with left atrial enlargement by left atrial volume but not by left atrial diameter
As for diameter measurements, LAE by volume was associated with increased LVMI, higher E/E ′ ratios, and higher proportion of LVH and advanced diastolic dysfunction, but with consistently stronger statistical significance than for LAE by diameter measurements ( Table 3) . Patients with LAE by volume but not by diameter measurements had a smaller BSA, LVMI, and prevalence of LVH and systolic dysfunction, but there was no difference in age, Impact of volumetric left atrial measurements on echocardiographic practice gender distribution, and the severity of diastolic dysfunction, when compared with patients with LAE by both methods ( Table 4) .
Discussion
The reported independent prognostic and risk stratification value of LAE in cardiovascular diseases is well established, 2,3,8,18 -22 although the relationship for cardiac events may be weaker in patients with atrial fibrillation. 10 The LA is an asymmetric 3D structure and may not dilate equally along its three axes, but there is no clear explanation why, in some patients, the anterior-posterior diameter is spared. The LA antero-posterior diameter is a readily available and time-established index of LAE with a proven prognostic value. 2, 8, 23 When compared with magnetic resonance, 3D echocardiography or computed tomography, LA 2D volumes have been consistently shown to be more accurate than linear dimension to diagnose LAE. 11, 12, 24, 25 LA volume measurements are advocated of late as being superior to linear measurements for prognostic purposes, 9,10 although the evidence for better prognostic and risk stratification power for the latter is scarce. In the paper of Tsang et al., 10 the LA-indexed volumes were superior by receiveroperating curve areas, but there was no difference in the hazards ratio of the two methods as predictors of cardiovascular events. Also, Pritchett et al. 9 report a better association with hypertension, heart failure, and atrial fibrillation for LA volumes, but there are no data on a possible prognostic value of LAE by volume as opposed to diameter. Whether volumetric measurements will become the established routine technique to diagnose LAE depends on feasibility and on the balance between the impact of a potential increase in the number of patients with reported abnormal findings and the real clinical benefits of adopting this method.
This paper
LA volume measurements could be obtained in 188 out of 200 patients, translating in a feasibility rate of 94%. LAE by both diameter and volume measurements was associated with higher LV mass and more advanced diastolic dysfunction, with the volume measurements showing a stronger statistical significance ( Table 2 ). The two methods were in agreement in only two-thirds of the patients for the diagnosis of LAE, mainly due to underdiagnosis by diameter measurements (86% of non-agreement cases). If LA volume rather than LA diameter was used, there was an abrupt increase (60%) in the percentage of patients reported to have LAE. These patients had lower LV mass and prevalence of LVH and systolic dysfunction and were less likely to be in atrial fibrillation or to have significant mitral valve disease, with borderline statistical significance. In 12 of them (24%), the LAE by volume measurement was the only echocardiographic abnormality. These results suggest that LA volume is a more sensitive marker than LA diameter for detecting LAE. Very little is known in the literature about the percentage of patients with LAE who are potentially missed by using linear measurements only and what are the determinants of discrepancies between the two methods. Badano et al. 26 report a 43% under-diagnosis rate of LAE by diameter measurements when compared with 3D volume reconstruction and in their study, indexing the LA anterior -posterior diameter to BSA also fails to improve diagnostic accuracy.
To the best of our knowledge, this is the first paper to specifically address the impact on LAE reporting of switching from linear measurements to a 2D volumetric approach. 
